Exact Mass: 585.1909776
Exact Mass Matches: 585.1909776
Found 163 metabolites which its exact mass value is equals to given mass value 585.1909776
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Montelukast
C35H36ClNO3S (585.2104296000001)
Montelukast is a leukotriene receptor antagonist (LTRA) used for the maintenance treatment of asthma and to relieve symptoms of seasonal allergies. It is usually administered orally. Montelukast blocks the action of leukotriene D4 on the cysteinyl leukotriene receptor CysLT1 in the lungs and bronchial tubes by binding to it. This reduces the bronchoconstriction otherwise caused by the leukotriene, and results in less inflammation. Because of its method of operation, it is not useful for the treatment of acute asthma attacks. Again because of its very specific locus of operation, it does not interact with other allergy medications such as theophylline. Montelukast is marketed in United States and many other countries by Merck & Co. with the brand name Singulair. It is available as oral tablets, chewable tablets, and oral granules. In India and other countries, it is also marketed under the brand name Montair®, produced by Indian company Cipla. R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03D - Other systemic drugs for obstructive airway diseases > R03DC - Leukotriene receptor antagonists D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D020024 - Leukotriene Antagonists D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists D065693 - Cytochrome P-450 Enzyme Inducers > D065694 - Cytochrome P-450 CYP1A2 Inducers COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
fosamprenavir
J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AE - Protease inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D000084762 - Viral Protease Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C97366 - HIV Protease Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent > C1660 - Anti-HIV Agent D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors
Fosamprenavir
Fosamprenavir is only found in individuals that have used or taken this drug. It is a prodrug of amprenavir, an inhibitor of human immunodeficiency virus (HIV) protease.Fosamprenavir is rapidly hydrolyzed to amprenavir by cellular phosphatases in the gut epithelium as it is absorbed. Amprenavir is an inhibitor of HIV-1 protease. During HIV replication, HIV protease cleaves viral polypeptide products of the Gag and Gag-Pol genes to form structural proteins of the virion core and essential viral enzymes. Amprenavir interferes with this process by binding to the active site of HIV-1 protease, thereby preventing the processing of viral Gag and Gag-Pol polyprotein precursors, resulting in the formation of immature non-infectious viral particles. J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AE - Protease inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D000084762 - Viral Protease Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C97366 - HIV Protease Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent > C1660 - Anti-HIV Agent D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors
9-Ethyl-4,6,9,10,11-pentahydroxy-7-[(2R,4S,5S,6S)-5-hydroxy-6-methyl-4-morpholin-4-yloxan-2-yl]oxy-8,10-dihydro-7H-tetracene-5,12-dione
2-[1-[[[(1R)-1-[3-[2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl]thio]methyl]cyclopropyl]acetic acid
C35H36ClNO3S (585.2104296000001)
Cadazolid
C29H29F2N3O8 (585.1922618000001)
Ezetimibe-glucuronide
Isoflavone base + 1O, 2MeO, O-Hex+C7H12NO
Annotation level-3
Astin B
astin B is a natural product found in Aster tataricus with data available.
Montelukast
C35H36ClNO3S (585.2104296000001)
R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03D - Other systemic drugs for obstructive airway diseases > R03DC - Leukotriene receptor antagonists D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D020024 - Leukotriene Antagonists D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists D065693 - Cytochrome P-450 Enzyme Inducers > D065694 - Cytochrome P-450 CYP1A2 Inducers COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE standard compound; INTERNAL_ID 2745
Cys Asp Trp Tyr
C27H31N5O8S (585.1893246000001)
Cys Asp Tyr Trp
C27H31N5O8S (585.1893246000001)
Cys Phe Met Trp
C28H35N5O5S2 (585.2079500000001)
Cys Phe Trp Met
C28H35N5O5S2 (585.2079500000001)
Cys Met Phe Trp
C28H35N5O5S2 (585.2079500000001)
Cys Met Trp Phe
C28H35N5O5S2 (585.2079500000001)
Cys Trp Asp Tyr
C27H31N5O8S (585.1893246000001)
Cys Trp Phe Met
C28H35N5O5S2 (585.2079500000001)
Cys Trp Met Phe
C28H35N5O5S2 (585.2079500000001)
Cys Trp Tyr Asp
C27H31N5O8S (585.1893246000001)
Cys Tyr Asp Trp
C27H31N5O8S (585.1893246000001)
Cys Tyr Trp Asp
C27H31N5O8S (585.1893246000001)
Asp Cys Trp Tyr
C27H31N5O8S (585.1893246000001)
Asp Cys Tyr Trp
C27H31N5O8S (585.1893246000001)
Asp Glu His Trp
Asp Glu Trp His
Asp His Glu Trp
Asp His Trp Glu
Asp Trp Cys Tyr
C27H31N5O8S (585.1893246000001)
Asp Trp Glu His
Asp Trp His Glu
Asp Trp Tyr Cys
C27H31N5O8S (585.1893246000001)
Asp Tyr Cys Trp
C27H31N5O8S (585.1893246000001)
Asp Tyr Trp Cys
C27H31N5O8S (585.1893246000001)
Glu Asp His Trp
Glu Asp Trp His
Glu His Asp Trp
Glu His Trp Asp
Glu Trp Asp His
Glu Trp His Asp
Phe Cys Met Trp
C28H35N5O5S2 (585.2079500000001)
Phe Cys Trp Met
C28H35N5O5S2 (585.2079500000001)
Phe Met Cys Trp
C28H35N5O5S2 (585.2079500000001)
Phe Met Trp Cys
C28H35N5O5S2 (585.2079500000001)
Phe Trp Cys Met
C28H35N5O5S2 (585.2079500000001)
Phe Trp Met Cys
C28H35N5O5S2 (585.2079500000001)
His Asp Glu Trp
His Asp Trp Glu
His Glu Asp Trp
His Glu Trp Asp
His Trp Asp Glu
His Trp Glu Asp
Met Cys Phe Trp
C28H35N5O5S2 (585.2079500000001)
Met Cys Trp Phe
C28H35N5O5S2 (585.2079500000001)
Met Phe Cys Trp
C28H35N5O5S2 (585.2079500000001)
Met Phe Trp Cys
C28H35N5O5S2 (585.2079500000001)
Met Ser Trp Tyr
Met Ser Tyr Trp
Met Trp Cys Phe
C28H35N5O5S2 (585.2079500000001)
Met Trp Phe Cys
C28H35N5O5S2 (585.2079500000001)
Met Trp Ser Tyr
Met Trp Tyr Ser
Met Tyr Ser Trp
Met Tyr Trp Ser
Ser Met Trp Tyr
Ser Met Tyr Trp
Ser Trp Met Tyr
Ser Trp Tyr Met
Ser Tyr Met Trp
Ser Tyr Trp Met
Trp Cys Asp Tyr
C27H31N5O8S (585.1893246000001)
Trp Cys Phe Met
C28H35N5O5S2 (585.2079500000001)
Trp Cys Met Phe
C28H35N5O5S2 (585.2079500000001)
Trp Cys Tyr Asp
C27H31N5O8S (585.1893246000001)
Trp Asp Cys Tyr
C27H31N5O8S (585.1893246000001)
Trp Asp Glu His
Trp Asp His Glu
Trp Asp Tyr Cys
C27H31N5O8S (585.1893246000001)
Trp Glu Asp His
Trp Glu His Asp
Trp Phe Cys Met
C28H35N5O5S2 (585.2079500000001)
Trp Phe Met Cys
C28H35N5O5S2 (585.2079500000001)
Trp His Asp Glu
Trp His Glu Asp
Trp Met Cys Phe
C28H35N5O5S2 (585.2079500000001)
Trp Met Phe Cys
C28H35N5O5S2 (585.2079500000001)
Trp Met Ser Tyr
Trp Met Tyr Ser
Trp Ser Met Tyr
Trp Ser Tyr Met
Trp Tyr Cys Asp
C27H31N5O8S (585.1893246000001)
Trp Tyr Asp Cys
C27H31N5O8S (585.1893246000001)
Trp Tyr Met Ser
Trp Tyr Ser Met
Tyr Cys Asp Trp
C27H31N5O8S (585.1893246000001)
Tyr Cys Trp Asp
C27H31N5O8S (585.1893246000001)
Tyr Asp Cys Trp
C27H31N5O8S (585.1893246000001)
Tyr Asp Trp Cys
C27H31N5O8S (585.1893246000001)
Tyr Met Ser Trp
Tyr Met Trp Ser
Tyr Ser Met Trp
Tyr Ser Trp Met
Tyr Trp Cys Asp
C27H31N5O8S (585.1893246000001)
Tyr Trp Asp Cys
C27H31N5O8S (585.1893246000001)
Tyr Trp Met Ser
Tyr Trp Ser Met
1-[[[(4S,4aS,5aS,6S,12aS)-4-(dimethylamino)-3,6,10,11,12a-pentahydroxy-6-methyl-1,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carbonyl]amino]methyl]piperidine-3-carboxylic acid
C29H35N3O10 (585.2322330000001)
Cadazolid
C29H29F2N3O8 (585.1922618000001)
D000890 - Anti-Infective Agents > D023303 - Oxazolidinones C254 - Anti-Infective Agent > C258 - Antibiotic
Titanium, tris(3-aminophenolato-.kappa.O)2,2-bis(2-propenyloxy-.kappa.O)methyl-1-butanolato-.kappa.O-, (OC-6-22)-
2-Des(1-hydroxy-1-methylethyl)-2-methycarboxy Montelukast
(1-{[(1-{3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl}-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl)sulfanyl]methyl}cyclopropyl)acetic acid
C35H36ClNO3S (585.2104296000001)
9-Ethyl-4,6,9,10,11-pentahydroxy-7-[(2R,4S,5S,6S)-5-hydroxy-6-methyl-4-morpholin-4-yloxan-2-yl]oxy-8,10-dihydro-7H-tetracene-5,12-dione
5-Methyl-tetrahydropteroyl-alpha-glutamylglutamate
[4-O-[4-O-(beta-D-Mannopyranosyl)-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl]-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl]amine
(2S)-2-[[(4S)-4-[[4-[(6aR)-3-amino-1-oxo-5,6,6a,7-tetrahydro-2H-imidazo[1,5-f]pteridin-10-ium-8-yl]benzoyl]amino]-4-carboxybutanoyl]amino]pentanedioic acid
2-(2,4-dimethoxyphenyl)-N-{4-methoxy-3-[(2,2,3,3-tetrafluoropropoxy)methyl]benzylidene}-4-quinolinecarbohydrazide
4,4,4-trifluoro-N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-(4-methylphenyl)sulfonylamino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]butanamide
C27H34F3N3O6S (585.2120300000001)
3-(2,5-difluorophenyl)-1-[[(4R,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-2-phenylethenyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-1-methylurea
3-(2,5-difluorophenyl)-1-[[(4S,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-2-phenylethenyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-1-methylurea
2-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(2-methoxyphenyl)methyl]acetamide
2-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(2-methoxyphenyl)methyl]acetamide
2-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-6-[[4-(trifluoromethyl)phenyl]carbamoylamino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-[(2-methoxyphenyl)methyl]acetamide
2-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-6-[[4-(trifluoromethyl)phenyl]carbamoylamino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-[(2-methoxyphenyl)methyl]acetamide
2-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-6-[[4-(trifluoromethyl)phenyl]carbamoylamino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-[(2-methoxyphenyl)methyl]acetamide
3-(2,5-difluorophenyl)-1-[[(4S,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-2-phenylethenyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-1-methylurea
3-(2,5-difluorophenyl)-1-[[(4S,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-2-phenylethenyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-1-methylurea
3-(2,5-difluorophenyl)-1-[[(4R,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-2-phenylethenyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-1-methylurea
3-(2,5-difluorophenyl)-1-[[(4R,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-2-phenylethenyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-1-methylurea
4,4,4-trifluoro-N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-(4-methylphenyl)sulfonylamino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]butanamide
C27H34F3N3O6S (585.2120300000001)